Ribavirin in chronic hepatitis C: past and future

Autor: Pierre Marquet, François Denis, Sophie Alain, Véronique Loustaud-Ratti, Annick Rousseau
Přispěvatelé: Biologie moléculaire et cellulaire des microorganismes (EA3175), Université de Limoges (UNILIM)-Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Bactériologie, Virologie, Hygiène [CHU Limoges], CHU Limoges, Pharmacologie des Immunosuppresseurs et de la Transplantation (PIST), Université de Limoges (UNILIM)-CHU Limoges-Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Limoges (UNILIM)
Rok vydání: 2009
Předmět:
MESH: Antiviral Agents
Microbiology (medical)
Hepacivirus
Treatment outcome
Alpha interferon
Antiviral Agents
Microbiology
MESH: Drug Synergism
Drug synergism
Polyethylene Glycols
chemistry.chemical_compound
Text mining
Chronic hepatitis
MESH: Drug Monitoring
MESH: Ribavirin
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Virology
Ribavirin
Humans
Medicine
MESH: Hepacivirus
ComputingMilieux_MISCELLANEOUS
MESH: Treatment Outcome
MESH: Humans
biology
business.industry
Interferon-alpha
Drug Synergism
Hepatitis C
Chronic
biology.organism_classification
[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology
MESH: Hepatitis C
Chronic
MESH: Drug Therapy
Combination
Treatment Outcome
Infectious Diseases
MESH: Polyethylene Glycols
chemistry
[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
Drug Therapy
Combination
Drug Monitoring
MESH: Interferon-alpha
business
Zdroj: Expert Review of Anticancer Therapy
Expert Review of Anticancer Therapy, Expert Reviews (formerly Future Drugs), 2009, 7 (3), pp.249-253. ⟨10.1586/eri.09.5⟩
ISSN: 1744-8336
1478-7210
1473-7140
1744-8328
DOI: 10.1586/eri.09.5
Popis: International audience
Databáze: OpenAIRE
Externí odkaz: